Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US3755581036
Ticker GILD
Company GILEAD SCIENCES
Currency $
Price
Aware Investor Index (AII) 64.6037
Recommendation STRONG BUY
P/E 12.76
ROE 31.49 %
Capitalization 86,484,960,000 $
Dividend Yield 3.45 %
P/S 3.91
AII Position 50
P/E Position 104
ROE Position 91
Capitalization Position 117
Dividend Yield Position 191
Sales 22,127,000,000 $
10-Year Average Earnings 6,780,002,300 $
Shares Outstanding 1,308,000,000
Equity 21,534,000,000 $
Dividend per Share 2.28 $
Industry Biotechnology
Country United States
GILEAD SCIENCES Investor Relations Web Site http://investors.gilead.com







Sales:

YEAR MONTH AMOUNT
2018 12 22,127,000,000.00 $
2017 12 26,107,000,000.00 $
2016 12 30,390,000,000.00 $
2015 12 32,639,000,000.00 $
2014 12 24,890,000,000.00 $
2013 12 11,201,680,000.00 $
2012 12 9,702,000,000.00 $
2011 12 8,385,000,000.00 $
2010 12 7,949,000,000.00 $
2009 12 7,011,000,000.00 $

Earnings:

YEAR MONTH AMOUNT
2018 12 5,455,000,000.00 $
2017 12 4,628,000,000.00 $
2016 12 13,501,000,000.00 $
2015 12 18,108,000,000.00 $
2014 12 12,101,000,000.00 $
2013 12 3,074,808,000.00 $
2012 12 2,591,566,000.00 $
2011 12 2,803,637,000.00 $
2010 12 2,901,257,000.00 $
2009 12 2,635,755,000.00 $

Equity:

YEAR MONTH AMOUNT
2018 12 21,534,000,000.00 $
2017 12 20,501,000,000.00 $
2016 12 19,363,000,000.00 $
2015 12 19,113,000,000.00 $
2014 12 15,819,000,000.00 $
2013 12 11,744,501,000.00 $
2012 12 9,550,869,000.00 $
2011 12 6,867,349,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2018 12 1,308,000,000
2017 12 1,319,000,000
2016 12 1,358,000,000
2015 12 1,521,000,000
2014 12 1,647,000,000
2013 12 1,694,747,000
2012 12 1,582,549,000
2011 12 1,580,236,000

 












Bloomberg News for GILEAD SCIENCES:



Google News for GILEAD SCIENCES:

The News Heater - 3 hours ago
Gilead Sciences, Inc. (GILD) – the Stock that gain 0.41% this week!
Gilead Sciences, Inc. (NASDAQ:GILD) went down by -0.52% from its latest closing price when compared to the 1-year high value of $79.61 and ...
Market Realist
Gilead Sciences (GILD) Gains As Market Dips: What You Should Know
In the latest trading session, Gilead Sciences (GILD) closed at $69.38, marking a +1.18% move from the previous day. This move outpaced the ...
NewsSmooth (press release)
Is Gilead Sciences (GILD) Outperforming Other Medical Stocks This ...
Investors focused on the Medical space have likely heard of Gilead Sciences (GILD), but is the stock performing well in comparison to the rest ...
Stocks Beat
Gilead's Latest Bolt-On Buys Point To A New Way Of Approaching ...
Gilead Sciences (GILD) announced a partnership with Nurix Therapeutics to develop potential drugs to treat cancer and other diseases. This is ...
Yahoo Finance - 3 Apr 2019
Diamond Hill Capital Management Stake In Gilead Sciences (GILD ...
Diamond Hill Capital Management Inc increased its stake in Gilead Sciences Inc. (GILD) by 5.97% based on its latest 2019Q1 regulatory filing ...
NewsSmooth (press release)
Gilead Sciences Inc (GILD): Short-Term Channel Update as ADX ...
Checking in on the short-term signals on Gilead Sciences Inc (GILD), we note that the current 7-day average directional indicator is Buy.
Stocks Beat
Gilead (GILD) Teams Up With Nurix for Cancer and Other Drugs
Biotech major Gilead Sciences, Inc. GILD collaborates with San Francisco-based Nurix Therapeutics, Inc. to discover, develop and ...
StreetInsider.com
Gilead Inks Deal With Carna Biosciences for Immuno-Oncology
Gilead Sciences, Inc. GILD entered a research and development collaboration with Japan-based biopharmaceutical company, Carna ...
Yahoo Finance - 12 Jun 2019
Is Gilead Sciences, Inc. (GILD) A Good Stock To Buy?
In this article we will check out hedge fund activity in another small-cap stock: Gilead Sciences, Inc. (NASDAQ:GILD). Is Gilead Sciences, Inc.
Finch News
Tristate Capital Holdings (TSC) Share Price Rose While Kennedy ...
Bb Biotech Ag decreased its stake in Gilead Sciences Inc. (GILD) by 14.26% based on its latest 2019Q1 regulatory filing with the SEC.


Back